Abstract:Age-dependent neurodegenerative diseases progressively form aggregates containing both shared components (e.g., TDP-43, phosphorylated tau) and proteins specific to each disease. We investigated whether diverse neuropathies might have additional aggregation-prone proteins in common, discoverable by proteomics. Caenorhabditis elegans expressing unc-54p/Q40::YFP, a model of polyglutamine array diseases such as Huntington's, accrues aggregates in muscle 2-6days posthatch. These foci, isolated on antibody-coupled magnetic beads, were characterized by high-resolution mass spectrometry. Three Q40::YFP-associated proteins were inferred to promote aggregation and cytotoxicity, traits reduced or delayed by their RNA interference knockdown. These RNAi treatments also retarded aggregation/cytotoxicity in Alzheimer's disease models, nematodes with muscle or pan-neuronal A(1-42) expression and behavioral phenotypes. The most abundant aggregated proteins are glutamine/asparagine-rich, favoring hydrophobic interactions with other random-coil domains. A particularly potent modulator of aggregation, CRAM-1/HYPK, contributed <1% of protein aggregate peptides, yet its knockdown reduced Q40::YFP aggregates 7286% (P<10(-6)). In worms expressing A(1-42), knockdown of cram-1 reduced -amyloid 60% (P<0.002) and slowed age-dependent paralysis >30% (P<10(-6)). In wild-type worms, cram-1 knockdown reduced aggregation and extended lifespan, but impaired early reproduction. Protection against seeded aggregates requires proteasome function, implying that normal CRAM-1 levels promote aggregation by interfering with proteasomal degradation of misfolded proteins. Molecular dynamic modeling predicts spontaneous and stable interactions of CRAM-1 (or human orthologs) with ubiquitin, and we verified that CRAM-1 reduces degradation of a tagged-ubiquitin reporter. We propose that CRAM-1 exemplifies a class of primitive chaperones that are initially protective and highly beneficial for early reproduction, but ultimately impair aggregate clearance and limit longevity.

Unraveling the Molecular Jam: How Crowding Shapes Protein Aggregation in Neurodegenerative Disorders

Protein Aggregation: Opposing Effects of Chaperones and Crowding

The Role of Crowded Physiological Environments in Prion and Prion-like Protein Aggregation

Proteins in Aggregates Functionally Impact Multiple Neurodegenerative Disease Models by Forming Proteasome-Blocking Complexes

The Contrasting Effect of Macromolecular Crowding on Amyloid Fibril Formation

Crowded Cell-Like Environment Accelerates The Nucleation Step Of Amyloidogenic Protein Misfolding

Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics

Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications

Macromolecular crowding effects on protein dynamics

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

Protein aggregation, misfolding and consequential human neurodegenerative diseases

Cell-to-cell Transmission of Pathogenic Proteins in Neurodegenerative Diseases

Molecular determinants of protein pathogenicity at the single-aggregate level

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Flavones Suppress Aggregation and Amyloid Fibril Formation of Human Lysozyme under Macromolecular Crowding Conditions

Transcellular transmission and molecular heterogeneity of aggregation-prone proteins in neurodegenerative diseases

Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition

Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases

The effects of biological crowders on fibrillization, structure, diffusion, and conformational dynamics of α‐synuclein